Opportunity Information: Apply for PAR 21 322

The Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) opportunity (PAR-21-322) is a National Institutes of Health (NIH) discretionary grant program that supports investigator-initiated R01 research focused on the biological and genetic mechanisms that contribute to cancer health disparities. The main goal is to move beyond describing disparities and instead dig into the underlying biology, including genetic, molecular, cellular, and related mechanistic factors that may help explain why certain populations experience differences in cancer risk, incidence, progression, outcomes, or response to prevention strategies. Because this FOA is labeled "Clinical Trial Not Allowed," projects should be basic or mechanistic in nature and should not propose prospective clinical intervention trials.

The FOA is designed to fund innovative research projects in several broad areas. First, it supports mechanistic studies of biological factors associated with cancer disparities, including research grounded in cancer biology and biology-driven cancer prevention concepts. Second, it encourages the development and testing of new methodologies and experimental models that can better capture the biological context of disparity populations, which can include improved analytic approaches, laboratory methods, or biologically relevant model systems. Third, it allows for secondary data analyses, meaning applicants can use existing datasets and resources to address mechanistic questions about disparities, as long as the work remains aligned with basic, biology-focused aims. A major emphasis is strengthening the field itself by expanding the tools and resources needed to do this kind of work, such as biospecimens, patient-derived models, and validated methods that can be shared or used broadly to accelerate progress.

A key workforce and infrastructure intent runs through the announcement: NIH is explicitly trying to build and sustain a nationwide cohort of scientists with strong basic research expertise in cancer health disparities. That translates into support for projects that not only answer specific mechanistic questions, but also help expand the practical capacity of the research community to study disparities at a biological level, for example by generating well-annotated biospecimen sets, establishing patient-derived systems, refining techniques that work well with limited or hard-to-access samples, or creating approaches that can be adopted by other groups investigating similar questions.

Eligibility is broad and includes many types of U.S.-based organizations as well as some non-U.S. entities. Eligible applicants listed include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (outside of higher education); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly highlights additional eligible applicant categories that are often central to disparities research capacity-building, including Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Indian/Native American Tribal Governments that are not federally recognized; faith-based or community-based organizations; eligible federal agencies; regional organizations; U.S. territories or possessions; and non-domestic (non-U.S.) entities (foreign organizations).

From an administrative standpoint, this is an NIH grant under CFDA 93.393 in the Education and Health activity area. The opportunity was created on 2021-09-02, and the original closing date shown is 2024-09-07. The listing does not specify an award ceiling or the expected number of awards in the provided data, which typically means applicants need to consult the full FOA and NIH institute-specific guidance for budget expectations, project period norms, and paylines or funding plans where applicable. Overall, the program is best suited for teams that can connect cancer disparities to testable biological mechanisms, leverage or build high-quality models and resources, and produce findings that strengthen the scientific foundation for understanding and ultimately reducing cancer inequities without conducting clinical trials.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393.
  • This funding opportunity was created on 2021-09-02.
  • Applicants must submit their applications by 2024-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 21 322

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Age-related Macular Degeneration (AMD) Integrative Biology Initiative: Discovery of AMD Pathobiology using Patient-Derived Induced Pluripotent Stem Cell (iPSC)-derived Retinal Pigment Epithelium (RPE) (U01 Clinical Trial Not Allowed)

Previous opportunity: OPE: Higher Education Emergency Relief Fund (HEERF), Section 2003 of the American Rescue Plan (ARP) for Institutions of Higher Education (IHE) that meet the criteria for the Minority Serving Institutions (MSIs) Program Assistance Listing Number 84.425L

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 21 322

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 21 322) also looked into and applied for these:

Funding Opportunity
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Apply for PAR 21 323

Funding Number: PAR 21 323
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) Apply for PAR 21 324

Funding Number: PAR 21 324
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $50,000
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) Apply for PAR 22 027

Funding Number: PAR 22 027
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) Apply for PAR 21 332

Funding Number: PAR 21 332
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) Apply for PAR 21 331

Funding Number: PAR 21 331
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) Apply for RFA DA 22 040

Funding Number: RFA DA 22 040
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional) Apply for RFA DA 22 028

Funding Number: RFA DA 22 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R21 - Clinical Trial Optional) Apply for RFA DA 22 039

Funding Number: RFA DA 22 039
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Apply for PAR 21 330

Funding Number: PAR 21 330
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Apply for PAR 21 302

Funding Number: PAR 21 302
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) Apply for PAR 21 301

Funding Number: PAR 21 301
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) Apply for PAS 21 270

Funding Number: PAS 21 270
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $1,000,000
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Independent Clinical Trial Not Allowed) Apply for PAR 21 300

Funding Number: PAR 21 300
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) Apply for PAR 21 299

Funding Number: PAR 21 299
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Pancreatic Cancer Detection Consortium: Management and Data Coordination Unit (U24 Clinical Trial Not Allowed) Apply for PAR 21 335

Funding Number: PAR 21 335
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Pancreatic Cancer Detection Consortium: Research Units (U01 Clinical Trial Optional) Apply for PAR 21 334

Funding Number: PAR 21 334
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) Apply for PAR 21 333

Funding Number: PAR 21 333
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $600,000
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed) Apply for RFA CA 21 059

Funding Number: RFA CA 21 059
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Apply for PAR 21 329

Funding Number: PAR 21 329
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed) Apply for RFA HL 22 013

Funding Number: RFA HL 22 013
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 322", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: